What is the story about?
Shares of Pine Labs
Ltd. are trading over 9% higher on Wednesday, April 8, after brokerage firm JPMorgan initiated coverage on the stock.
JPMorgan has initiated coverage with a 'Neutral' rating and a price target of ₹165 per share, implying a potential upside of over 9% from current levels.
The brokerage said that Pine Labs has been a pioneer in in-store payments infrastructure and affordability solutions.
It has also expanded into adjacent segments, including online payments, issuing, and financial technology infrastructure, through a mix of organic growth and acquisitions.
JPMorgan highlighted that Pine Labs operates in a large and growing total addressable market for digital payments, and expects a compound annual growth rate of 23% to 25% between financial year 2024 and financial year 2029.
It also sees earnings before interest, tax, depreciation and amortisation margins expanding to around 27% by financial year 2028.
Last month, Jefferies cut its price target on Pine Labs by 13.3% to ₹260 per share from ₹300 earlier.
According to available analyst recommendations, two analysts each have 'Buy' and 'Hold' ratings on the stock, while one analyst has a 'Sell' rating.
Shares of Pine Labs were last trading 9.13% higher at ₹170.87, although the stock continues to remain below its issue price.
JPMorgan has initiated coverage with a 'Neutral' rating and a price target of ₹165 per share, implying a potential upside of over 9% from current levels.
The brokerage said that Pine Labs has been a pioneer in in-store payments infrastructure and affordability solutions.
It has also expanded into adjacent segments, including online payments, issuing, and financial technology infrastructure, through a mix of organic growth and acquisitions.
JPMorgan highlighted that Pine Labs operates in a large and growing total addressable market for digital payments, and expects a compound annual growth rate of 23% to 25% between financial year 2024 and financial year 2029.
It also sees earnings before interest, tax, depreciation and amortisation margins expanding to around 27% by financial year 2028.
Last month, Jefferies cut its price target on Pine Labs by 13.3% to ₹260 per share from ₹300 earlier.
According to available analyst recommendations, two analysts each have 'Buy' and 'Hold' ratings on the stock, while one analyst has a 'Sell' rating.
Shares of Pine Labs were last trading 9.13% higher at ₹170.87, although the stock continues to remain below its issue price.
/images/ppid_59c68470-image-177555011188260873.webp)
/images/ppid_59c68470-image-177557507581323743.webp)
/images/ppid_59c68470-image-177561752997866162.webp)
/images/ppid_59c68470-image-177554005701499397.webp)
/images/ppid_59c68470-image-177553004167916641.webp)
/images/ppid_59c68470-image-177552503849954384.webp)
/images/ppid_59c68470-image-177554502500655280.webp)
/images/ppid_59c68470-image-177562507431751598.webp)
/images/ppid_59c68470-image-177545003185021435.webp)
/images/ppid_59c68470-image-177555007258686301.webp)
/images/ppid_59c68470-image-177553507885829778.webp)
/images/ppid_59c68470-image-177554257269941477.webp)